The DOI matches its Crossref record; 76 of the 79 references it cites were found in a registry or an index; 6 of the 32 sources its claims cite were checked for support.
The Flaws and Human Harms of Animal Experimentation
Open accessAbstract
Nonhuman animal (“animal”) experimentation is typically defended by arguments that it is reliable, that animals provide sufficiently good models of human biology and diseases to yield relevant information, and that, consequently, its use provides major human health benefits. I demonstrate that a growing body of scientific literature critically assessing the validity of animal experimentation generally (and animal modeling specifically) raises important concerns about its reliability and predictive value for human outcomes and for understanding human physiology. The unreliability of animal experimentation across a wide range of areas undermines scientific arguments in favor of the practice. Additionally, I show how animal experimentation often significantly harms humans through misleading safety studies, potential abandonment of effective therapeutics, and direction of resources away from more effective testing methods. The resulting evidence suggests that the collective harms and costs to humans from animal experimentation outweigh potential benefits and that resources would be better invested in developing human-based testing methods.
Overview
CoChat Summary
## TL;DR
Aysha Akhtar argues that animal experimentation is broadly unreliable for predicting human outcomes because of laboratory effects, poor disease models, and species differences. She concludes that this unreliability causes significant human harms and that research resources should shift to human-based testing methods.
## Key findings
- The paper states that more than 115 million animals are used worldwide annually in experimentation or to supply the biomedical industry.
- In a cited 2007 systematic review, animal and clinical trial results for interventions in head injury, respiratory distress syndrome, osteoporosis, stroke, and hemorrhage matched only half of the time.
- The paper reports that the FDA estimated in 2004 that 92% of drugs that pass preclinical tests, including animal tests, fail to reach the market; a later analysis suggested the failure rate is closer to 96%.
- It gives multiple examples of translation failure, including more than 114 potential therapies for stroke that failed in human trials after animal testing, more than twenty drugs that failed in ALS trials, and all of about 90 HIV vaccines that succeeded in animals but failed in humans.
## Methods
- This is a narrative argument/review drawing on a growing body of scientific literature on the validity of animal experimentation, including systematic reviews, comparative studies, and illustrative case examples.
- The paper synthesizes evidence across several domains: laboratory environment effects, discordance between animal models and human diseases, and interspecies differences in physiology and genetics.
- The main analysis is qualitative: it weighs reported translational failures and harms to argue that animal experimentation is poorly predictive of human outcomes.
## Limitations
- The paper states that the efficacy of animal experimentation has been subjected to little systematic scrutiny and that much pharmaceutical preclinical data are proprietary and publicly unavailable, limiting precise counts of missed opportunities.
- It acknowledges that some methodological problems in animal studies can be addressed by better standardization, but argues these efforts are insufficient; this is a limitation of the approach as discussed in the text, not a formal study limitation.
- The text does not present a primary empirical study with a defined sample, so its conclusions depend on the scope and selection of cited literature; this is evident from the text.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
2 Valid · 5 Not valid · 26 Not checked · 21 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“I show that animal experimentation is poorly predictive of human outcomes,4 that it is unreliable across a wide category of disease areas,5 and that existing literature demonstrates the unreliability of animal experimentation, thereby undermining scientific arguments in its favor.”
§ The Flaws and Human Harms of Animal Experimentation > Introduction
What the sources say
- Partly supportedcites [5] sourceExperimental — accuracy not yet measured
The Summary Points report recurrent failures of promising animal-model interventions to translate to clinical trials, and give examples involving pancreatitis, stroke, and myocardial infarction (page not specified). But the paper frames predictive value as controversial and discusses disease-specific disparities; it does not establish that animal experimentation as a whole is unreliable across a wide range of disease areas. (LLM, conf=0.84)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“Despite decades of using animal models, not a single neuroprotective agent that ameliorated spinal cord injury in animal tests has proven efficacious in clinical trials to date.46”
§ The Flaws and Human Harms of Animal Experimentation > Problems of Successful Translation to Humans of Data from Animal Experimentation > Interspecies Differences in Physiology and Genetics
What the sources say
- Could not verifycites [46] sourceExperimental — accuracy not yet measured
Our copy discusses human–mouse differences in transcription-factor binding in liver cells and their implications for mouse models (Abstract; page unavailable). Searches for spinal cord injury, neuroprotective agents, and clinical trials found no passage addressing whether agents successful in animal tests proved efficacious in humans. (LLM, conf=0.78)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“The high clinical failure rate in drug development across all disease categories is based, at least in part, on the inability to adequately model human diseases in animals and the poor predictability of animal models.36”
§ The Flaws and Human Harms of Animal Experimentation > Problems of Successful Translation to Humans of Data from Animal Experimentation > The Discordance between Human Diseases and Animal Models of Diseases
What the sources say
- Could not verifycites [36] sourceExperimental — accuracy not yet measured
The Limitations and Statistical Power and Analyses sections concern a human trial of conjugated equine estrogen, not drug-development failure rates. Searches for animal models, preclinical studies, and their predictive value found no passage addressing the claim. Passage-level page numbers were not available in our copy. (LLM, conf=0.76)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“More recent analysis suggests that, despite efforts to improve the predictability of animal testing, the failure rate has actually increased and is now closer to 96 percent.39”
§ The Flaws and Human Harms of Animal Experimentation > Problems of Successful Translation to Humans of Data from Animal Experimentation > The Discordance between Human Diseases and Animal Models of Diseases
What the sources say
- Could not verifycites [39]Experimental — accuracy not yet measured
The Discussion says stress from laboratory routines may lessen the reliability of animal studies, but it does not report a failure rate or a trend over time. Searches for the 96% figure and for animal-testing predictability found no passage addressing those claims in our copy. (LLM, conf=0.76)
hedgedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
Every source the paper cites for this claim was checked and supports it.
In the paper
“Even if the design and conduct of an animal experiment are sound and standardized, the translation of its results to the clinic may fail because of disparities between the animal experimental model and the human condition.21”
§ The Flaws and Human Harms of Animal Experimentation > Problems of Successful Translation to Humans of Data from Animal Experimentation > The Discordance between Human Diseases and Animal Models of Diseases
What the sources say
- Supportedcites [21] source
The Review’s Theory section explains that species can respond differently to the same stimuli because of biological differences, limiting extrapolation from animals to humans. The Predicting human response section also describes clinical failures despite rigorous preclinical testing. Together, these support the claim that sound animal experiments may not translate to the clinic. (LLM, conf=0.88)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
36 more claims · 1 with their cited sources checked
Create a free account to see all 54 claims and to verify the 1 reference still open.
- It may state two separate claims as one. 13
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“although a number of studies do demonstrate continued problems with predicting human efficacy (73).”
From Limitations of Animal Studies for Predicting Toxicity in Clinical Trials (2019) · cites this paper as [73]
In the citing paper
“the results offer little guidance to human toxicity reactions, due to inter-species differences and differential disease models [6,7].”
From Machine Learning Based Toxicity Prediction: From Chemical Structural Description to Transcriptome Analysis (2018) · cites this paper as [7]
Citations
Cites
Writing Group for the Women's Health Initiative Investigators (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.3.321 · Cited by 15,889
Genomic responses in mouse models poorly mimic human inflammatory diseases
Seok, J., Warren, H. S., Cuenca, A. G., Mindrinos, M. N., Baker, H. V., Xu, W., Richards, D. R., McDonald-Smith, G. P., Gao, H., Hennessy, L., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1222878110 · Cited by 3,005
Genetics of Mouse Behavior: Interactions with Laboratory Environment
Crabbe, J. C., Wahlsten, D., & Dudek, B. C. (1999) · Science · doi:10.1126/science.284.5420.1670 · Cited by 1,666 · cited 1×
“19 Additionally, different mouse strains varied markedly in all behavioral tests, and for some tests the magnitude of genetic differences depended on the specifi c testing laboratory.”
1,026 Experimental treatments in acute stroke
O'Collins, V. E., Macleod, M. R., Donnan, G. A., Horky, L. L., van der Worp, B. H., & Howells, D. W. (2006) · Annals of Neurology · doi:10.1002/ana.20741 · Cited by 1,460
Animal models of traumatic brain injury
Xiong, Y., Mahmood, A., & Chopp, M. (2013) · Nature Reviews Neuroscience · doi:10.1038/nrn3407 · Cited by 1,408
Can Animal Models of Disease Reliably Inform Human Studies?
van der Worp, H. B., Howells, D. W., Sena, E. S., Porritt, M. J., Rewell, S., O'Collins, V., & Macleod, M. R. (2010) · PLoS Medicine · doi:10.1371/journal.pmed.1000245 · Cited by 1,354
Update of the Stroke Therapy Academic Industry Roundtable Preclinical Recommendations
Fisher, M., Feuerstein, G., Howells, D. W., Hurn, P. D., Kent, T. A., Savitz, S. I., & Lo, E. H. (2009) · Stroke · doi:10.1161/strokeaha.108.541128 · Cited by 1,352
Sources of stress in captivity
Morgan, K. N., & Tromborg, C. T. (2007) · Applied Animal Behaviour Science · doi:10.1016/j.applanim.2006.05.032 · Cited by 1,085 · cited 1×
“8 Among the types of laboratory-generated distress is the phenomenon of contagious anxiety.”
(2006) · Elsevier eBooks · doi:10.1016/b978-0-12-074903-4.x5000-6 · Cited by 1,073
Research works printed but not linked: 2
- Hart, 2009, Translational Neuroscience and Its Advancement of Animal Research Ethics, 71
- Woodroofe, 2007, ServiceNote: Human tissue research for drug discovery, Genetic Engineering and Biotechnology News, 27, 18
Cited by
Limitations of Animal Studies for Predicting Toxicity in Clinical Trials
Van Norman, G. A. (2019) · JACC: Basic to Translational Science · doi:10.1016/j.jacbts.2019.10.008 · Cited by 732
“number of studies do demonstrate continued problems with predicting human efficacy (73).”
BackgroundSeyhan, A. A. (2019) · Translational Medicine Communications · doi:10.1186/s41231-019-0050-7 · Cited by 713
Rahaman, M. M., Hossain, R., Herrera‐Bravo, J., Islam, M. T., Atolani, O., Adeyemi, O. S., Owolodun, O. A., Kambizi, L., Daştan, S. D., Calina, D., et al. (2023) · Food Science & Nutrition · doi:10.1002/fsn3.3217 · Cited by 374
“Akhtar, A. (2015). The flaws and human harms of animal experimentation. Cambridge Quarterly of Healthcare Ethics: CQ, 24, 407– 419. Alshehri, M. M., Quispe, C., Herrera- Bravo, J., Sharifi- Rad, J., Tutuncu, S., Aydar, E. F., Topkaya, C., Mertdinc, Z., Ozcelik, B., Aital, M., Kumar, N. V. A., Lapava, N., Rajkovic, J.,…”
BackgroundInfluentialLee, J.-E., Jayakody, J., Kim, J.-I., Jeong, J.-W., Choi, K.-M., Kim, T.-S., Seo, C., Azimi, I., Hyun, J., & Ryu, B. (2024) · Foods · doi:10.3390/foods13193151 · Cited by 318
“Animal models often face limitations due to biological differences and experimental design constraints, making it difficult to directly apply findings to humans [19].”
BackgroundIngber, D. E. (2020) · Advanced Science · doi:10.1002/advs.202002030 · Cited by 277
Metadata
- Authors
- AKHTAR, A.
- Affiliations
- University of Oxford (GB)
- Corresponding author
- AKHTAR, AYSHA
- Venue
- Cambridge Quarterly of Healthcare Ethics
- Publisher
- Cambridge University Press (CUP)
- Published
- 2015-09-14
- Volume
- 24
- Issue
- 4
- Pages
- 407-419
- ISSN
- 0963-1801 (ISSN-L)
- 1469-2147
- PMC
- PMC4594046
- OpenAlex
- W2108829078
- Cited by
- 527
- References
- 79
- Citations by year
- 2026: 58 · 2025: 69 · 2024: 101 · 2023: 72 · 2022: 55 · 2021: 37 · 2020: 44 · 2019: 39 · 2018: 22 · 2017: 13 · 2016: 13 · 2015: 3
- FWCI
- 27.35
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Cambridge Quarterly of Healthcare Ethics (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- WBI Studies Repository (submittedVersion)
- WBI Studies Repository (submittedVersion, cc-by)
- Greater South Information System
- Topics
- Health Sciences › Veterinary › Small Animals › Animal testing and alternatives
- Social Sciences › Law › Animal Law and Welfare
- Health Sciences › Nursing › Issues, ethics and legal aspects › Biomedical Ethics and Regulation
- Keywords
- animal experimentation, animal models of human disease, predictive validity, animal welfare
- MeSH terms
- Animals, Animal Welfare, Disease Models, Animal, Drug Industry, Humans, Animal Rights, Toxicity Tests, Animal Experimentation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Flaws and Human Harms of Animal Experimentation. https://app.cochat.ai/papers/10.1017/s0963180115000079
- The paper
- AKHTAR, A. (2015). The Flaws and Human Harms of Animal Experimentation. Cambridge Quarterly of Healthcare Ethics. https://doi.org/10.1017/s0963180115000079
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.